内科理论与实践

内科理论与实践 >

2021 , Vol. 16 >Issue 03: 151 - 154

DOI: https://doi.org/10.16138/j.1673-6087.2021.03.003

专家论坛

主动脉瓣狭窄合并冠心病患者的经导管主动脉瓣置换联合介入治疗

展开
  • 中国医学科学院阜外医院冠心病中心,北京 100037

收稿日期: 2021-04-23

  网络出版日期: 2022-07-26

收起

本文引用格式

王墨扬, 陈阳, 叶蕴青, 张洪亮, 吴永健 . 主动脉瓣狭窄合并冠心病患者的经导管主动脉瓣置换联合介入治疗[J]. 内科理论与实践, 2021 , 16(03) : 151 -154 . DOI: 10.16138/j.1673-6087.2021.03.003

参考文献

[1] Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients[J]. N Engl J Med, 2011, 364(23): 2187-2198.
[2] Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients[J]. New Engl J Med, 2016, 374(17): 1609-1620.
[3] Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients[J]. New Engl J Med, 2017, 376(14): 1321-1331.
[4] Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients[J]. N Engl J Med, 2019, 380(18): 1695-1705.
[5] Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients[J]. N Engl J Med, 2019, 380(18): 1706-1715.
[6] Walther T, Hamm CW, Schuler G, et al. Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY registry[J]. J Am Coll Cardiol, 2015, 65(20): 2173-2180.
[7] D’Ascenzo F, Verardi R, Visconti M, et al. Independent impact of extent of coronary artery disease and percutaneous revascularisation on 30-day and one-year mortality after TAVI: a meta-analysis of adjusted observational results[J]. EuroIntervention, 2018, 14(11): e1169-e1177.
[8] Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease[J]. Circulation, 2021, 143(5): e72-e227.
[9] van den Boogert TPW, Vendrik J, Claessen BEPM, et al. CTCA for detection of significant coronary artery disease in routine TAVI work-up[J]. Neth Heart J, 2018, 26(12): 591-599.
[10] Faroux L, Guimaraes L, Wintzer-Wehekind J, et al. Coronary artery disease and transcatheter aortic valve replacement[J]. J Am Coll Cardiol, 2019, 74(3): 362-372.
[11] Tarus A, Tinica G, Bacusca A, et al. Coronary revascularization during treatment of severe aortic stenosis[J]. J Cardiac Surg, 2020, 35(8): 2009-2016.
[12] Blumenstein J, Kim WK, Liebetrau C, et al. Challenges of coronary angiography and intervention in patients previously treated by TAVI[J]. Clin Res Cardiol, 2015, 104(8): 632-639.
[13] van Rosendael PJ, van der Kley F, Kamperidis V, et al. Timing of staged percutaneous coronary intervention before transcatheter aortic valve implantation[J]. Am J Cardiol, 2015, 115(12): 1726-1732.
[14] Singh V, Rodriguez AP, Thakkar B, et al. Comparison of outcomes of transcatheter aortic valve replacement plus percutaneous coronary intervention versus transcatheter aortic valve replacement alone in the United States[J]. Am J Cardiol, 2016, 118(11): 1698-1704.
[15] Penkalla A, Pasic M, Drews T, et al. Transcatheter aortic valve implantation combined with elective coronary artery stenting: a simultaneous approach[J]. Eur J Cardiothorac Surg, 2015, 47(6): 1083-1089.
[16] Barbanti M, Todaro D, Costa G, et al. Optimized screening of coronary artery disease with invasive coronary angiography and ad hoc percutaneous coronary intervention during transcatheter aortic valve replacement[J]. Circ Cardiovasc Interv, 2017, 10(8): e005234.
[17] Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry[J]. J Am Coll Cardiol, 2013, 62(17): 1552-1562.
[18] Rodés-Cabau J, Ribeiro HB. Consolidating the BASILICA technique in TAVI patients at risk of coronary obstruction[J]. EuroIntervention, 2020, 16(8): 617-619.
[19] Vilalta V, Asmarats L, Ferreira-Neto AN, et al. Incidence, clinical characteristics, and impact of acute coronary syndrome following transcatheter aortic valve replacement[J]. JACC Cardiovasc Interv, 2018, 11(24): 2523-2533.
[20] Mentias A, Desai MY, Saad M, et al. Incidence and outcomes of acute coronary syndrome after transcatheter aortic valve replacement[J]. JACC Cardiovasc Interv, 2020, 13(8): 938-950.
[21] Tang GHL, Zaid S, Fuchs A, et al. Alignment of transcatheter aortic-valve neo-commissures (ALIGN TAVR): impact on final valve orientation and coronary artery overlap[J]. JACC Cardiovasc Interv, 2020, 13(9): 1030-1042.
Options
文章导航

/

〈 〉